Sprint Bioscience AB (OSTO:SPRINT) YoY EBITDA Growth : 56.02% (As of Jun. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Sprint Bioscience AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Sprint Bioscience AB's YoY EBITDA Growth for the quarter that ended in Jun. 2024 was 56.02%.

Sprint Bioscience AB's EBITDA per Share for the three months ended in Jun. 2024 was kr-0.07.

Sprint Bioscience AB YoY EBITDA Growth Historical Data

The historical data trend for Sprint Bioscience AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sprint Bioscience AB YoY EBITDA Growth Chart

Sprint Bioscience AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

YoY EBITDA Growth

Get a 7-Day Free Trial

45.97

-46.19

66.23

100.00

Sprint Bioscience AB Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
YoY EBITDA Growth	Get a 7-Day Free Trial															62.78	224.92	-	77.01	56.02

Sprint Bioscience AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Sprint Bioscience AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (A: Dec. 2023 )
=	(EBITDA per Share (A: Dec. 2023 )	-	EBITDA per Share (A: Dec. 2022 ))	/	\| EBITDA per Share (A: Dec. 2022 ) \|
=	(-0.03	-	0)	/	\| 0 \|
=	N/A %

Sprint Bioscience AB's YoY EBITDA Growth for the quarter that ended in Jun. 2024 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2024 )
=	(EBITDA per Share (Q: Jun. 2024 )	-	EBITDA per Share (Q: Jun. 2023 ))	/	\| EBITDA per Share (Q: Jun. 2023 )) \|
=	(-0.073	-	-0.166)	/	\| -0.166 \|
=	56.02 %

Sprint Bioscience AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Sprint Bioscience AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Sprint Bioscience AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sprint Bioscience AB (OSTO:SPRINT) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

5JA1:Germany

Address

Halsovagen 7, Floor 8, Elevator A, Novum, Huddinge, SWE, 141 57

Website

http://www.sprintbioscience.com

Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.

Sprint Bioscience AB Headlines

No Headlines